REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 82 filers reported holding REPROS THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $288,000 | -58.1% | 29,149 | -26.6% | 0.00% | – |
| Q2 2014 | $687,000 | +84.7% | 39,733 | +89.1% | 0.00% | – |
| Q1 2014 | $372,000 | +564.3% | 21,016 | +585.9% | 0.00% | – |
| Q4 2013 | $56,000 | -65.6% | 3,064 | -49.8% | 0.00% | – |
| Q3 2013 | $163,000 | -94.4% | 6,100 | -96.2% | 0.00% | -100.0% |
| Q2 2013 | $2,925,000 | – | 158,553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,132,367 | $9,727,000 | 2.05% |
| RTW INVESTMENTS, LP | 229,364 | $1,970,000 | 0.89% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 361,300 | $3,104,000 | 0.85% |
| DESTRIER CAPITAL MANAGEMENT LLC | 329,030 | $2,826,000 | 0.73% |
| SENZAR ASSET MANAGEMENT, LLC | 244,006 | $2,096,000 | 0.51% |
| GENERAL AMERICAN INVESTORS CO INC | 508,375 | $4,367,000 | 0.36% |
| CQS Cayman LP | 700,000 | $6,013,000 | 0.28% |
| Rotella Capital Management, Inc. | 20,800 | $179,000 | 0.15% |
| Baker Brothers Advisors | 2,000,000 | $17,180,000 | 0.14% |
| Gruss Capital Management LP | 304,000 | $2,611,000 | 0.11% |